The association of circulating amylin with β-amyloid in familial Alzheimer's disease.

Han LyNirmal VermaSavita SharmaDeepak KotiyaSanda DespaErin L AbnerPeter T NelsonGregory A JichaDonna M WilcockLarry B GoldsteinRita GuerreiroJosé BrásAngela J HansonSuzanne CraftAndrew J MurrayGeert Jan BiesselsClaire TroakesHenrik ZetterbergJohn HardyTammaryn Lashleynull AesgFlorin Despa

Published in: Alzheimer's & dementia (New York, N. Y.) (2021)

These findings strengthened the hypothesis of circulating amylin-AD interaction and suggest that modulation of blood amylin levels may alter Aβ-related pathology/symptoms.

Keyphrases

cognitive decline
early onset
physical activity
mild cognitive impairment
drug induced